SLP - Simulations Plus, Inc.
NEXT EARNINGS:
Apr 2, 2026
EPS Est: $0.27
|
Rev Est: $21.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$56.00
DETAILS
HIGH:
$65.00
LOW:
$47.00
MEDIAN:
$56.00
CONSENSUS:
$56.00
UPSIDE:
383.18%
Market Cap:
233.50M
Volume:
268,228
Avg Volume:
379,195
52 Week Range:
11.41-36.45
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Beta:
1.13
Last Dividend:
$0.24
Exchange:
NASDAQ
Country:
US
Employees:
243
IPO Date:
1997-06-18
EPS (TTM):
-3.22
P/E Ratio:
-4.40
Revenue (TTM):
79.18M
Total Assets:
131.94M
Total Debt:
616,000
Cash & Equiv:
30.85M
Rev Growth (5Y):
13.7%
EPS Growth (5Y):
0.4%
FCF Growth (5Y):
15.9%
ROCE:
5.2%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-08 | $0.13 | $0.18 | -27.8% | $18.4M | $21.9M | -15.9% |
| 2025-12-01 | $0.10 | $0.10 | 0.0% | $17.5M | $17.4M | +0.4% |
| 2025-07-14 | $0.45 | $0.26 | +73.1% | $20.4M | $20.9M | -2.7% |
| 2025-04-03 | $0.31 | $0.25 | +24.0% | $22.4M | $21.9M | +2.3% |
| 2025-01-07 | $0.17 | $0.18 | -5.6% | $18.9M | $18.8M | +0.6% |
| 2024-10-23 | $0.06 | $0.07 | -9.1% | $18.7M | $19.7M | -5.5% |
| 2024-07-02 | $0.15 | $0.15 | 0.0% | $18.5M | $19.8M | -6.4% |
| 2024-04-03 | $0.20 | $0.19 | +5.3% | $18.3M | $17.3M | +5.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 79.18M | 70.01M | 59.58M | 53.91M | 46.47M | 41.59M | 33.97M | 29.67M | 24.14M | 19.97M | 18.31M | 11.46M |
| Net Income | (64.72M) | 9.95M | 9.96M | 12.48M | 9.78M | 9.33M | 8.58M | 8.93M | 5.79M | 4.95M | 3.84M | 3.03M |
| EPS | -3.22 | 0.50 | 0.50 | 0.62 | 0.49 | 0.52 | 0.49 | 0.52 | 0.34 | 0.29 | 0.23 | 0.19 |
| Total Assets | 131.94M | 207.64M | 192.64M | 190.50M | 181.61M | 169.82M | 46.09M | 44.15M | 38.51M | 27.81M | 27.34M | 20.98M |
| Total Debt | 616,000 | 1.01M | 1.20M | 1.40M | 1.28M | 926,777 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 30.85M | 10.31M | 57.52M | 51.57M | 36.98M | 49.21M | 11.44M | 9.40M | 6.22M | 8.03M | 8.55M | 8.61M |
| Operating Cash Flow | 18.13M | 13.32M | 21.86M | 17.90M | 19.20M | 10.91M | 11.64M | 9.29M | 6.88M | 5.42M | 7.13M | 5.31M |
| Free Cash Flow | 17.41M | 12.75M | 17.58M | 13.93M | 14.63M | 8.33M | 9.68M | 6.96M | 5.32M | 4.18M | 5.89M | 1.41M |
| FCF per Share | 0.87 | 0.64 | 0.88 | 0.69 | 0.73 | 0.47 | 0.55 | 0.40 | 0.31 | 0.25 | 0.35 | 0.09 |
| Book Value | 124.80M | 182.43M | 170.03M | 178.25M | 165.78M | 156.04M | 37.68M | 31.92M | 25.80M | 22.73M | 19.53M | 15.44M |
| Cash & ST Investments | 32.35M | 20.25M | 115.46M | 128.24M | 123.60M | 116.01M | 11.44M | 9.40M | 6.22M | 8.03M | 8.55M | 8.61M |
| ROC Equity | -0.52 | 0.05 | 0.06 | 0.07 | 0.06 | 0.06 | 0.23 | 0.28 | 0.22 | 0.22 | 0.20 | 0.20 |